|
BBS10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.839800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.446200E-01 |
| Normal-vs-Stage2 |
1.264390E-01 |
| Normal-vs-Stage3 |
5.063600E-01 |
| Normal-vs-Stage4 |
3.449000E-01 |
| Stage1-vs-Stage2 |
3.303000E-01 |
| Stage1-vs-Stage3 |
9.420800E-01 |
| Stage1-vs-Stage4 |
5.496800E-01 |
| Stage2-vs-Stage3 |
4.149000E-01 |
| Stage2-vs-Stage4 |
9.111800E-01 |
| Stage3-vs-Stage4 |
5.952600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.201010E-01 |
| Normal-vs-AfricanAmerican |
7.703800E-02 |
| Normal-vs-Asian |
9.491600E-01 |
| Caucasian-vs-AfricanAmerican |
4.431000E-01 |
| Caucasian-vs-Asian |
7.458600E-01 |
| AfricanAmerican-vs-Asian |
5.730000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.385780E-01 |
| Normal-vs-Female |
2.794000E-02 |
| Male-vs-Female |
1.834040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.577200E-01 |
| Normal-vs-Extreme_Weight |
9.334000E-01 |
| Normal-vs-Obese |
6.818000E-02 |
| Normal-vs-Extreme_Obese |
6.856400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.493200E-01 |
| Normal_Weight-vs-Obese |
6.510500E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.722800E-01 |
| Extreme_Weight-vs-Obese |
8.222300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.054400E-01 |
| Obese-vs-Extreme_Obese |
6.029400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.302410E-02 |
| Normal-vs-Age(41-60Yrs) |
2.716000E-03 |
| Normal-vs-Age(61-80Yrs) |
7.536400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.810600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.077400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.803800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.104100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.500500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.057810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.910800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.242800E-03 |
| Normal-VS-Type2 PRCC |
3.295600E-01 |
| Normal-VS-KIRP CIMP |
6.552600E-01 |
| Normal-VS-Unclassified PRCC |
1.663550E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.402700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.668800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.725560E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.716000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.296000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.158640E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.624000E-01 |
| Normal-vs-N1 |
1.053250E-01 |
| Normal-vs-N2 |
9.861400E-01 |
| N0-vs-N1 |
1.292990E-01 |
| N0-vs-N2 |
9.298800E-01 |
| N1-vs-N2 |
4.961000E-01 |
|
|
